Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EBOS GROUP LIMITED Major Shareholding Notification 2019

Nov 17, 2019

64813_rns_2019-11-17_c7d2e698-104d-4ed2-98ea-b4de4e384b8a.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

==> picture [183 x 54] intentionally omitted <==

18 November 2019

NZX / ASX Code: EBO

Sybos partial sell-down

EBOS Group Limited (NZX, ASX: EBO) ( EBOS ) has been advised that its largest shareholder Sybos Holdings Pte Limited ( Sybos ), which holds 60,525,721 ordinary shares in EBOS (37.33%), has today entered into an underwriting agreement with a financial institution to sell a portion of its shares ( Sale ).

To ensure an equally informed market, EBOS advises that it considers that it is in compliance with its continuous disclosure and financial reporting obligations. EBOS considers, having made enquiry, that it does not currently possess any information that it is withholding from disclosure under an exception, nor is it relying on any waiver, under either the NZX Listing Rules or the ASX Listing Rules. EBOS understands that Sybos will sell the relevant shares without regulated disclosure under the Australian Corporations Act 2001 or the New Zealand Financial Markets Conduct Act 2013.

Yours faithfully

==> picture [108 x 40] intentionally omitted <==

Janelle Cain General Counsel EBOS Group Limited

Important notice

This announcement has been prepared by EBOS on the basis of information available to it at the time of preparation, and from information provided by Sybos. No representation or warranty, express or implied, is made or given by or on behalf of EBOS, any of its directors, or any other person about the accuracy, completeness or fairness of the information contained in this notice and to the maximum extent permitted by law, no responsibility or liability is accepted by any of them for that information or for any errors, omissions, statements (negligent or otherwise) or for any communication written or otherwise, contained or referred to in this notice. This notice is not for release to US wire services or for distribution in the United States

To the extent that the Sale is being made in reliance upon the exclusion in clause 19 of Schedule 1 to the Financial Markets Conduct Act 2013, this announcement is made under clause 20(1)(a) of Schedule 8 to Financial Markets Conduct Regulations 2014 and section 708A(5)(e) of the Australian Corporations Act 2001 as modified by ASIC Instrument 2016/81 and EBOS has confirmed the information that would be required for a formal cleansing notice under the relevant Australian and New Zealand legislation.

EBOS Group Limited. NZBN 9429031998840 Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia. PO Box 7300, Melbourne, Victoria 8004, Australia. Phone: +61 3 9918 5555, Fax: +61 3 9918 5599. www.ebosgroup.com

2

For further information, please contact:

Shaun Hughes CFO, EBOS Group Ltd +61 428 833 981

About EBOS:

EBOS Group Limited is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading marketer and distributor of recognised consumer products and animal care brands.